docturnal
Hyderabad, Telangana, India
About docturnal
Docturnal offers custom content for diabetes, heart, cancer, Autism, and Arthritis for users who have a condition or their concerned ones. The company is a point of care screening and diagnostics provider of non-invasive and proactive detection of diseases. Docturnal’s product portfolio also includes solutions for CoPD and Asthma with a pipeline of lung based ailments that can be identified by an aural component. Docturnal products are designed to make detection of diseases easy and hassle-free. Essentially it means being accessible and affordable to the last mile. Docturnal was established in April 2016.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: $1K – $10K
- Total funding: $14.7K
- Funding stage: Seed
- Last round: Grant (Jul 2021)
- Website: docturnal.com
- Phone: [email protected]
Industries & Categories
Biotechnology, Diabetes, Health Care, Health Diagnostics
Social Profiles
Canonical: https://fsome.com/organization/docturnal-2245232 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.